Erythromycin is a prescription antibacterial drug used for treatment of multiple susceptible bacterial infections and selected prophylactic indications. Labeling includes respiratory, skin, chlamydial, pertussis, and other organism-specific indications, with susceptibility-guided use emphasized to limit resistance. It is an established oral antibacterial agent with broad historical clinical use.
GC Biopharma said a review paper in Human Vaccines & Therapeutics analyzed more than 40 studies on its MAV/06 varicella vaccine strain. The paper summarized 30 years of data showing 99-100% neutralizing antibody rates and adverse event incidence of 0.41 to 0.57 cases per 100,000 doses.
A joint report from the European Food Safety Authority and the European Centre for Disease Prevention and Control finds antimicrobial resistance in Salmonella and Campylobacter continues to pose a public health concern across Europe, though several countries have reported progress in reducing resistance levels.
